Erlotinib (Tarceva®): a promising drug targeting epidermal growth factor receptor tyrosine kinase

AM Bulgaru, S Mani, S Goel… - Expert review of …, 2003 - Taylor & Francis
Overexpression of the epidermal growth factor receptor (EGFR) is correlated with a poor
prognosis in several human malignancies. In addition, cancers overexpressing EGFR …
被引用次数：62 相关文章

Erlotinib (Tarceva®): a promising drug targeting epidermal growth factor receptor tyrosine kinase

AM Bulgaru, S Mani, S Goel… - Expert Review of …, 2003 - search.proquest.com
Overexpression of the epidermal growth factor receptor (EGFR) is correlated with a poor
prognosis in several human malignancies. In addition, cancers overexpressing EGFR …

Erlotinib (Tarceva): a promising drug targeting epidermal growth factor receptor tyrosine kinase.

AM Bulgaru, S Mani, S Goel… - Expert Review of …, 2003 - europepmc.org
Overexpression of the epidermal growth factor receptor (EGFR) is correlated with a poor
prognosis in several human malignancies. In addition, cancers overexpressing EGFR …

Erlotinib (Tarceva®): A promising drug targeting epidermal growth factor receptor tyrosine kinase

AM Bulgaru, S Mani, S Goel… - Expert Review of …, 2003 - einstein.elsevierpure.com
Overexpression of the epidermal growth factor receptor (EGFR) is correlated with a poor
prognosis in several human malignancies. In addition, cancers overexpressing EGFR …

Erlotinib (Tarceva): a promising drug targeting epidermal growth factor receptor tyrosine kinase

AM Bulgaru, S Mani, S Goel… - Expert review of …, 2003 - pubmed.ncbi.nlm.nih.gov
Overexpression of the epidermal growth factor receptor (EGFR) is correlated with a poor
prognosis in several human malignancies. In addition, cancers overexpressing EGFR …